Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 31
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Biol Regul Homeost Agents ; 35(1): 171-183, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33491346

RESUMEN

The coronavirus disease 2019 (COVID-19) pandemic is a worldwide medical challenge due to the scarcity of proper information and remedial resources. The ability to efficiently avoid a further SARS-CoV-2 pandemic will, therefore, depend on understanding several factors which include host immunity, virus behavior, prevention measures, and new therapies. This is a multi-phase observatory study conducted in the SG Moscati Hospital of Taranto in Italy that was converted into COVID-19 Special Care Unit for SARS-Co-V2 risk management. Patients were admitted to the 118 Emergency Pre-Hospital and Emergency Department based on two diagnostic criteria, the nasopharyngeal swab assessed by reverse-transcriptase-polymerase-chain-reaction (RT-PCR) and CT-scan image characterized by ground glass opacity. Patients were divided into four groups, positive-positive (ER-PP), negative-positive (ER-NP), negative-negative (ER-NN) and a group admitted to the ICU (ER-IC). A further control group was added when the T and B lymphocyte subsets were analyzed. Data included gender, age, vital signs, arterial blood gas analysis (ABG), extensive laboratory results with microbiology and bronchoalveolar lavage fluid (BALF) which were analyzed and compared. Fundamental differences were reported among the groups. Males were significantly higher in PP, ICU, and NP groups, from 2 to 4-fold higher than females, while in the NN group, the number of females was mildly higher than males; the PP patients showed a marked alkalotic, hypoxic, hypocapnia ABG profile with hyperventilation at the time of admission; finally, the laboratory and microbiology results showed lymphopenia, fibrinogen, ESR, CRP, and eGFR were markedly anomalous. The total number of CD4+ and CD8+ T cells was dramatically reduced in COVID-19 patients with levels lower than the normal range delimited by 400/µL and 800/µL, respectively, and were negatively correlated with blood inflammatory responses.


Asunto(s)
COVID-19/diagnóstico , COVID-19/fisiopatología , Femenino , Hospitalización , Hospitales , Humanos , Unidades de Cuidados Intensivos , Italia , Masculino , Pandemias
2.
Clin Ter ; 173(2): 128-134, 2022 Apr 04.
Artículo en Inglés | MEDLINE | ID: mdl-35385035

RESUMEN

Background: The objective of this study was to evaluate the relia-bility and validity of the lifestyle (Miller-Smith) and life expectancy (Schneider) questionnaires in the Italian setting in order to make this instrument available for the determination of lifestyle and hope level in the different domains of everyday life. Method: Before testing their psychometric properties, the original versions of the two questionnaires, lifestyle (Miller-Smith) and life expectancy (Schneider), were translated into the Italian language. We tested the instrument's psychometric properties on a sample of 18 patients over 60 years old with Alzheimer's disease in the Sapienza University of Rome teaching hospital, policlinico Umberto 1. Internal consistency was considered to assess the reliability of the results across items within the adopted scale by using Cronbach's α coefficient. Using Kolmogorov-Smirnov's test, the normality distribution was evaluated to guarantee the applicability of a parametric or non-parametric test. The software used to analyze data was SPSS version 26 for Windows. Results: According to the outcome of our statistical analysis, the lifestyle scale showed high overall internal consistency, and the Cron-bach's α coefficient for the total 20-item scale was 0.80 in the Italian population. On the other hand, using the 12-item questionnaire about life expectancy resulted in a high overall internal consistency of 0.93, according to the Cronbach's alpha test. Conclusions: The outcome of our study shows that the Italian versions of the lifestyle (Miller-Smith) and life expectancy (Schneider) questionnaires demonstrated good psychometric properties and good characteristics of factorial validity for future epidemiological studies aimed at evaluating lifestyle and lifestyle expectancy in the Italian population and can as well be used in clinical practice and research.


Asunto(s)
Lenguaje , Estilo de Vida , Humanos , Italia , Esperanza de Vida , Persona de Mediana Edad , Psicometría , Calidad de Vida , Reproducibilidad de los Resultados , Encuestas y Cuestionarios
3.
Arch Gerontol Geriatr ; 44 Suppl 1: 61-7, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17317435

RESUMEN

The MS is associated with increased morbidity and mortality for cardiovascular disease (CVD). MS is represented not only by metabolic alteration such as hyperglycemia, and hyperlipemia but also by a chronic pro-inflammatory state. Another responsible in the formation and progression of CVD is the so-called endothelial dysfunction, which is linked to insulin resistance itself. The common denominator of the MS is insulin resistance. The most convincing evidence for the existence of MS comes from the cluster analysis which outlines four main factors: the "metabolic factor", the "pressure factor", the "lipid factor" and the "obesity factor". It is clear that the presence of the MS appears to identify a substantial additional cardiovascular risk on top of the individual risk factors. The studies available in the literature have pointed out the beneficial effects, in terms of cardiovascular mortality, of the treatment with inhibitors of the 3-hydroxy-3-methylglutaryl coenzyme A reductase (statins): this reduction of risk has been observed despite the fact that high triglyceride and low high-density lipoprotein (HDL)-cholesterol levels, but not hypercholesterolemia, are the main features of the dyslipidemia observed in patients with MS. Yet, despite a normal low-density lipoprotein (LDL)-cholesterol level, patients with MS are at high risk for future CVD. For this reason, their treatment with statins is mandatory.


Asunto(s)
Diabetes Mellitus/fisiopatología , Síndrome Metabólico/epidemiología , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus/epidemiología , Fluorobencenos/uso terapéutico , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipercolesterolemia/sangre , Hipercolesterolemia/epidemiología , Síndrome Metabólico/tratamiento farmacológico , Pirimidinas/uso terapéutico , Rosuvastatina Cálcica , Sulfonamidas/uso terapéutico
4.
Arch Gerontol Geriatr ; 44 Suppl 1: 105-11, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17317442

RESUMEN

Several studies have shown a relationship between BISH and cerebrovascular events, but no studies have investigated a relationship with cognitive function. The aim was to assess the cognitive function in the elderly with recent BISH. According to WHO Guidelines (1999), we selected 10 elderly normotensives, 10 elderly with recently diagnosed (<2 years) BISH, and 10 elderly with recently diagnosed (<2 years) isolated systolic hypertension (ISH). They were submitted to 24-hr ambulatory blood pressure (BP) monitoring (ABPM) and to cognitive assessment by mini mental state examination (MMSE) and the recording of brain ERP, of type N2 and P300. The elderly with BISH, compared to normotensives, showed N2 wave latency values significantly higher, but similar P300 potential latency values and MMSE scores. The elderly with ISH showed N2 and P300 latency significantly higher than the normotensives. The gradual increase of the ERP latency values of the BISH and ISH elderly, in comparison to the normotensives, seems to indicate a gradual alteration of the cognitive processes related to the increase of BP.


Asunto(s)
Encéfalo/fisiopatología , Trastornos del Conocimiento/epidemiología , Potenciales Evocados/fisiología , Hipertensión/epidemiología , Hipertensión/fisiopatología , Anciano , Antropometría , Monitoreo Ambulatorio de la Presión Arterial/métodos , Trastornos del Conocimiento/diagnóstico , Humanos , Hipertensión/diagnóstico , Pruebas Neuropsicológicas , Índice de Severidad de la Enfermedad
5.
Arch Gerontol Geriatr ; 44 Suppl 1: 385-9, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17317480

RESUMEN

Sleep is an active nervous process, which is structured in phases characterized by subsequent cycles of various psycho-physiological phenomena. It performs vital, yet mysterious functions and is in all likelihood involved in many processes, including cognitive processes. In old age the internal structure of sleep changes, but these physiological variations allow, in healthy subjects, a satisfactory quantity and quality of sleep. Until now there have been no literature reports of studies regarding sleep quality in extreme old age. Our work describes the investigation of the quality of sleep in a sample of 180 centenarians selected from the registered residents of Rome. We have studied sleep disorders, related pathologies and pharmacological treatments. The results of the study show good sleep quality for 57.4% of the sample group; 35.2% complain of medium intensity problems, significantly related to angina pectoris and to chronic obstructive bronchopneumopathy. Only 7.4% of the subjects showed severe problems, significantly related with cognitive deficiency and lower survival rate. The results of our study confirm, in centenarians as in the elderly, the existence of a positive correlation between sleep quality, survival and successful aging.


Asunto(s)
Sueño/fisiología , Sobrevivientes/estadística & datos numéricos , Anciano de 80 o más Años , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/epidemiología , Estado de Salud , Humanos , Pruebas Neuropsicológicas , Privación de Sueño/epidemiología , Vigilia/fisiología
6.
J Nutr Health Aging ; 21(5): 593-596, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28448092

RESUMEN

OBJECTIVE: Impairment of physical performance might identify older people at higher risk of dementia over time. The present study evaluated handgrip strength as independent predictor of cognitive decline. DESIGN: Observational, prospective. Follow-up duration: 11.2 ± 0.8 months. SETTING AND PARTICIPANTS: Geriatric outpatients center. 104 consecutive stroke- and dementia-free older adults (44% men, ages 80.2 ± 5.4 years). METHODS: The Clinical Dementia Rating scale and the Clock Drawing Test (CDT) were administered. Handgrip strength was assessed using a Jamar hand dynamometer. Brain magnetic resonance imaging studies at 1.5 T were performed. White matter damage was expressed as severity of white matter hyperintensities (WMHs). Longitudinal changes in cognitive function were expressed as 1-year decline in CDT performance. RESULTS: A robust association was observed between baseline handgrip strength and 1-year cognitive decline after multiple adjustment. Of note, the strength of such association was only minimally attenuated after adjusting for deep WMHs extent (ß coefficient for handgrip strength = 0.183, SE= 0.038, p= 0.007, R2= 0.58). CONCLUSIONS: Handgrip strength predicted accelerated 1-year decline in cognitive function, assessed by CDT, in a sample of older adults. Future studies are needed to elucidate the causal mechanisms linking limitations in physical function with dementia risk.


Asunto(s)
Cognición , Disfunción Cognitiva , Fuerza de la Mano , Análisis y Desempeño de Tareas , Anciano , Anciano de 80 o más Años , Disfunción Cognitiva/etiología , Demencia , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Estudios Prospectivos , Accidente Cerebrovascular , Sustancia Blanca
7.
Drug Alcohol Depend ; 16(1): 51-60, 1985 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3905314

RESUMEN

The purpose of this paper is to describe some of the main themes which highlighted the work of the Society for the Study of Addiction (SSA) in Britain through the years 1930-1961. The major focus of this paper is on alcoholism with special reference to alcoholism treatment. After presenting some general background during this historical period of the Society, three themes will be discussed: visible changes within the treatment framework, sobriety and the argument of strain, and the rise of the alcoholism treatment unit.


Asunto(s)
Alcoholismo/historia , Sociedades/historia , Alcoholismo/terapia , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Reino Unido
8.
Soc Sci Med ; 39(12): 1667-73, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7846564

RESUMEN

The study examines the factors contributing to the initiation, continuation and termination of use among female and male long-term users of minor and major tranquilizers. The findings show the importance of the lay-referral system as a channel of introduction to psychotropic drug use, especially for men. The issue of dependency is explored both in terms of the users' own interpretation of its nature and their reports on the professional responses to their long-term use. The findings indicate that gender and drug use are intricately linked in both the non-professional and professional treatment of anxiety and insomnia.


Asunto(s)
Ansiolíticos , Antipsicóticos , Trastornos Relacionados con Sustancias/epidemiología , Ansiolíticos/uso terapéutico , Antipsicóticos/uso terapéutico , Trastornos de Ansiedad/tratamiento farmacológico , Trastornos de Ansiedad/epidemiología , Estudios Transversales , Femenino , Finlandia/epidemiología , Humanos , Incidencia , Cuidados a Largo Plazo/estadística & datos numéricos , Masculino , Factores Sexuales , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico , Trastornos del Inicio y del Mantenimiento del Sueño/epidemiología
9.
Arch Gerontol Geriatr ; 28(2): 117-23, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-15374091

RESUMEN

The impact of hypertension on survival in extremely old age has shown different features in different studies, with equal or lower mortality rates in hypertensive patients and lower reduction of risk in treated patients. In a population (n=414) of old community dwellers (mean age 88.4 years) the prevalence of hypertension was 52.2%. Hypertensive patients presented a lower mortality rate (14.2 per 100 person-years) as compared to the general population (15.4) and to non-hypertensives (16.6). Hypertensives were divided into four groups according to treatment. Best survival was shown by patients under treatment with antihypertensives alone (9.8) or in association with diuretics (9.9), and worst survival by patients under a diuretic-based treatment (25.1). These data were confirmed by multivariate analysis. The better survival of hypertensive very old people could be related to the use of a proper pharmacotherapy.

10.
Sociology ; 34(3): 403-20, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12449935

RESUMEN

This paper's purpose is to highlight key sociological issues, that come to light when 'the body' becomes a theoretical site in reproductive genetics. By positioning the body as a central feature in this analysis, the paper: (1) describes how a mechanistic view of the body continues to be privileged in this discourse and the effects of this view; (2) examines how reproductive limits are practised on the gendered body through a feminised regime of reproductive asceticism and the discourse on shame; and (3) explores the social effects and limitations of reproductive genetics in relation to disability as a cultural representation of impaired bodies. The central assumption concerning reproductive genetics are that it appears within surveillance medicine as a part of a disciplinary process in society's creation of a genetic moral order, that it is mobilised by experts for the management of reproductive bodies and that it constructs a limited view of the body. Thus, the way reproductive genetics operatives tends to hide the fact that what may appear as 'defective genes' is a result of a body's interaction not only with the environment but also gendered social practices valorised by difference as well as rigid definitions of health and illness. The research is from a 1995-96 European study of experts interviewed in four countries.


Asunto(s)
Pruebas Genéticas/psicología , Poder Psicológico , Mujeres Embarazadas/psicología , Diagnóstico Prenatal/psicología , Controles Informales de la Sociedad , Actitud del Personal de Salud , Coerción , Mercantilización , Personas con Discapacidad/psicología , Femenino , Finlandia , Asesoramiento Genético/ética , Asesoramiento Genético/psicología , Pruebas Genéticas/ética , Grecia , Cuerpo Humano , Humanos , Países Bajos , Embarazo , Prejuicio , Diagnóstico Prenatal/ética , Política Pública , Investigación Cualitativa , Reproducción , Reino Unido
11.
Recenti Prog Med ; 91(9): 450-4, 2000 Sep.
Artículo en Italiano | MEDLINE | ID: mdl-11021168

RESUMEN

Alzheimer's disease is a neurodegenerative disease that causes a progressive decline of cognitive and behavioural functions. The simultaneous presence of these disorders requires a treatment not only for cognitive decline, but also for behavioural symptoms, depression and caregiver's stress. Research has made many efforts to develop a wide range of treatments, different from current pharmacological therapy, which is not resolutive, owing to the absence of an exact etiopathogenetic mechanism. Since new drugs have not been shown to be really effective in slowing cognitive impairment, various forms of rehabilitative interventions have been proposed in order to treat Alzheimer's disease. Their efficacy in the improvement of cognitive functions is still not completely clear. Surely, interesting results have been obtained from studies about Reality Orientation Therapy, Occupational Therapy and Memory Training. Music therapy might provide a new form of rehabilitative intervention, especially acting on the reducing of behavioural symptoms. These alternative forms of non pharmacological treatment may have a positive effect on caregiver. The heavy emotional burden of seeing a loved one becoming confused and isolated and of having to accept new responsibilities, may be reduced by rehabilitative supports, complementary to the pharmacological therapy. Caregiver stress could be reduced in two ways: by promoting the hope that something is being done for the patient and providing free time for himself.


Asunto(s)
Enfermedad de Alzheimer/rehabilitación , Cuidadores/psicología , Humanos , Memoria , Musicoterapia , Terapia Ocupacional , Psicoterapia , Terapia de la Realidad
12.
Minerva Med ; 105(2): 167-74, 2014 Apr.
Artículo en Italiano | MEDLINE | ID: mdl-24727881

RESUMEN

AIM: Vascular dementia (VaD) is defined as a loss of cognitive function resulting from ischemic, hypoperfusive, or hemorrhagic brain lesions due to cerebrovascular disease or cardiovascular pathology. The main types of VaD are: Small Vessel Disease Dementia (sVAD), Large vessel disease dementia, hypoperfusive-ischemic dementia and hemorragic dementia. The sVAD is divided into two main categories: subcortical ischemic vascular dementia (SIVD) and cortical dementia. Currently, no drugs are approved for the treatment of VaD. This study aimed to determine whether rivastigmine, a second generation cholinesterase inhibitor with selectivity for the CNS, with capacity to inhibit both acetylcholinesterase (AChE) and butyryl-cholinesterase (BuChE), slows the rate of cognitive decline associated with VaD. METHODS: Study subjects were 27 male and 43 female outpatients aged 80.03±6.53 years, with Mini-Mental State Examination (MMSE) score ranging batween 22 and 12, affected by VaD. They were included in the study if they were undergoing pharmacological treatment with acetylsalicylic acid 100 mg for at least six months. Patients were divided into two groups: one group was treated with ASA 100 mg and rivastigmine patch 9.5 mg (Rivastigmine group), the other just with ASA 100 mg (ASA group). All patients were followed for 6 months, with a first evaluation (T0) and a second examination after six mounths of treatment (T1). RESULTS: Statistically data proved as the Rivastigmine group showed constant values at MMSE, compared with patients of the ASA group who experienced decline of their cognitive performances. The same result was found in CDR, ADL, GDS and NPI scales. It is remarkable to underline as Rivastigmine-treated patients had a mean improvement in GDS scales, in comparison with patients of the ASA group who showed a worsening of mood. CONCLUSION: Rivastigmine-therapy improves cognitive performance in elderly with SIVD.


Asunto(s)
Acetilcolinesterasa , Butirilcolinesterasa , Inhibidores de la Colinesterasa/uso terapéutico , Cognición/efectos de los fármacos , Demencia Vascular/tratamiento farmacológico , Fármacos Neuroprotectores/uso terapéutico , Fenilcarbamatos/uso terapéutico , Anciano , Anciano de 80 o más Años , Antiinflamatorios no Esteroideos/uso terapéutico , Aspirina/uso terapéutico , Demencia Vascular/clasificación , Progresión de la Enfermedad , Femenino , Humanos , Masculino , Escala del Estado Mental , Rivastigmina
13.
Complement Ther Med ; 22(4): 614-20, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25146063

RESUMEN

OBJECTIVE: Recent studies have thrown doubt on the true effectiveness of anti-depressants in light and moderate depression. The aim of this study is to evaluate the impact of physical training and music therapy on a sample group of subjects affected by light to moderate depression versus subjects treated with pharmacological therapy only. DESIGN AND SETTING: Randomized controlled study. Patients were randomized into two groups. Subjects in the pharmacotherapy group received a therapy with antidepressant drugs; the exercise/music therapy group was assigned to receive physical exercise training combined with listening to music. The effects of interventions were assessed by differences in changes in mood state between the two groups. MAIN OUTCOME MEASURES: Medically eligible patients were screened with the Hamilton Anxiety Scale and with the Geriatric Depression Scale. We used plasmatic cytokine dosage as a stress marker. RESULTS: We recruited 24 subjects (mean age: 75.5 ± 7.4, 11 M/13 F). In the pharmacotherapy group there was a significant improvement in anxiety only (p<0.05) at 6-months. In the exercise/music therapy was a reduction in anxiety and in depression at 3-months and at 6-months (p<0.05). We noted an average reduction of the level of TNF-a from 57.67 (± 39.37) pg/ml to 35.80 (± 26.18) pg/ml. CONCLUSIONS: Our training may potentially play a role in the treatment of subjects with mild to moderate depression. Further research should be carried out to obtain more evidence on effects of physical training and music therapy in depressed subjects.


Asunto(s)
Ansiedad/terapia , Trastorno Depresivo/terapia , Terapia por Ejercicio/métodos , Musicoterapia/métodos , Anciano , Anciano de 80 o más Años , Ansiolíticos/efectos adversos , Ansiolíticos/uso terapéutico , Ansiedad/epidemiología , Trastorno Depresivo/epidemiología , Femenino , Humanos , Masculino , Proyectos Piloto , Resultado del Tratamiento
14.
Arch Gerontol Geriatr ; 56(1): 27-31, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22088935

RESUMEN

Cognitive impairment is an age-related condition as the rate of cognitive decline rapidly increases with aging. The aim of this study was to screen the risk of cognitive decline in people over 60 years from 16 different Italian cities, by comparing the results of a self-administered questionnaire with the MMSE. We analyzed data from 203 persons aged 60 years and over, who voluntarily accepted to participate during the "Second Prevention Day for AD". A self-administered questionnaire, developed by clinicians of our Department of Aging, was distributed to all participants, in order to easily screen the risk of cognitive impairment. Then, all subjects underwent cognitive assessment by MMSE. We esteemed the risk of cognitive impairment of all participants basing on MMSE scores (no risk, mild and moderate risk) and we compared this assessment with the results obtained by the self-administered questionnaire. The comparison between the risk of cognitive impairment revealed by our questionnaire and the risk esteemed by MMSE resulted in a discrepancy in 43.96% of cases in no risk class. In mild risk group there was a discrepancy of results in 70.53% of subjects. In moderate risk class there was a discrepancy of results in 38.46% of individuals. Our questionnaire resulted to be accurate for the evaluation of patients with moderate risk of cognitive impairment. It showed a lower accuracy for the mild risk class, often overestimating the risk of cognitive decline.


Asunto(s)
Demencia/diagnóstico , Pruebas Neuropsicológicas , Encuestas y Cuestionarios , Anciano , Demencia/etiología , Femenino , Humanos , Italia/epidemiología , Modelos Lineales , Masculino , Pruebas Neuropsicológicas/normas , Proyectos Piloto , Factores de Riesgo , Encuestas y Cuestionarios/normas
15.
Arch Gerontol Geriatr ; 54(2): 330-2, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21632127

RESUMEN

Few therapeutic options are available nowadays to improve the prognosis of patients with Alzheimer's disease (AD). There are rather several evidences in literature that controlling vascular risk factors may be an effective intervention for modifying the course of this disease. The aim of our study was to investigate the role of CRF in 50 patients with MCI according to Petersens's criteria, and to evaluate their influence on cognitive and behavioral features of the disease and on the development of dementia. Statistical analysis of the data showed that the 60% of the patients with MCI and CRF developed dementia, while 40% maintained the same cognitive conditions at the end of the study. Only 32% of the subjects without cardiovascular comorbidities developed dementia. The results of the study suggest that CRF play a key role in cognitive decline of patients with MCI. Patients with MCI and CRF showed not only worse cognitive performances, but also behavioral disorders, depression and functional disability. Patients with CRF had higher conversion rate to AD than the other group, with a mean disease-free period 3 months shorter than the control group.


Asunto(s)
Enfermedades Cardiovasculares/complicaciones , Disfunción Cognitiva/etiología , Anciano , Enfermedades Cardiovasculares/psicología , Enfermedades de las Arterias Carótidas/complicaciones , Enfermedades de las Arterias Carótidas/psicología , Demencia/etiología , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/psicología , Progresión de la Enfermedad , Femenino , Humanos , Hiperlipidemias/complicaciones , Hiperlipidemias/psicología , Hipertensión/complicaciones , Hipertensión/psicología , Masculino , Pruebas Neuropsicológicas , Factores de Riesgo , Índice de Severidad de la Enfermedad , Fumar/efectos adversos , Factores de Tiempo
16.
Arch Gerontol Geriatr ; 51(3): e79-82, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20138674

RESUMEN

The ME was described for the first time in 1993. Subsequently other studies with similar designs were performed. The present study, therefore, proposes: (i) to verify the existence of the benefits of exposure to music in elderly subjects with mild cognitive impairment (MCI), (ii) to explore whether it is possible to find any lasting improvement after training, conducted for a long period of time, with such musical pieces, in the measurable cognitive performances. The study we conducted showed that the ME is present in geriatric patients with MCI; the influence on spatial-temporal abilities remains constant in time if the stimulation is maintained. The continuation of our study will consist of increasing the number of individuals examined and in having them listen to music during the study of ECG rhythms and during the acquisition of cerebral functional magnetic resonance imaging (fMRI), and, at the same time, testing them by neuropsychometric methods.


Asunto(s)
Trastornos del Conocimiento/rehabilitación , Música/psicología , Anciano , Percepción Auditiva/fisiología , Femenino , Evaluación Geriátrica , Humanos , Masculino , Psicometría/métodos , Percepción Espacial/fisiología , Análisis y Desempeño de Tareas , Resultado del Tratamiento
18.
Arch Gerontol Geriatr ; 49 Suppl 1: 71-6, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19836618

RESUMEN

Atrial fibrillation (AF), which is a very common disease among the elderly, is already well known as a risk factor for arterial thromboembolism and stroke. The attention of medical research is now focused on establishing a possible role of AF in the development of cognitive impairment in order to include this arrhythmia among risk factors for dementia. The aim of this work was to investigate the relationship between AF and various types of dementia, such as vascular dementia (VaD), Alzheimer's disease (AD) and mixed dementia (MD). The study consisted of 71 VaD, AD or MD patients, 31 males and 40 females. The sample has been divided in 2 groups according to the sex, and these two groups have been analyzed separately. In females, a statistically significant association was found between mini mental state examination (MMSE) and clinical dementia rating (CDR) scores and AF occurrence (r=-0.32; p<0.05; r=0.33; p<0.05). On the contrary, no significant linear correlation was found between AF and a lower activities if daily living (ADL) and instrumental activities if daily living (IADL) scores. In males, AF/MMSE, AF/CDR, AF/ADL and AF/IADL variables have not been found to be linearly related to each other. Unexpectedly, AF turned to be associated to AD more often than to VAD, becoming a possible risk factor for this neurodegenerative disease. Our results are supported by many studies in literature attributing a basic role of brain hypoperfusion in sporadic AD patho-genesis. More and more scientific data suggest that the already well known risk factors for AD could be considered just the top of an iceberg, providing powerful arguments for impaired cerebral perfusion as the primary trigger in the development of this disease. Moreover, the mildly favorable treatment response in patients with AD to therapy that improves cerebral blood flow is a consistent finding; the same cannot be said of antiamyloid treatments. This opens new possibilities to find an effective way to treat this dramatic pathology.


Asunto(s)
Fibrilación Atrial/complicaciones , Isquemia Encefálica/complicaciones , Demencia/etiología , Anciano , Anciano de 80 o más Años , Isquemia Encefálica/diagnóstico , Isquemia Encefálica/epidemiología , Demencia/diagnóstico , Demencia/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Incidencia , Italia/epidemiología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Tomografía Computarizada por Rayos X
19.
Arch Gerontol Geriatr ; 49 Suppl 1: 185-94, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19836632

RESUMEN

Inflammation is believed to play a pivotal role in dementia, but its role is still unclear. The aim of our study was to analyze the interplay among markers of inflammation, such as fibrinogen and high CRP levels, and dementia. First, we performed a cross-sectional study comparing markers of inflammation between 99 patients affected by dementia (mean age: 83.0+/-0.6 years) and 99 controls (mean age: 83.9+/-0.7 years). Then, we analyzed the relationship between inflammation and dementia in the same population composed by 34 Alzheimer's disease (AD) patients (mean age: 83.4+/-0.8 years), 64 vascular dementia (VaD) patients (mean age: 82.7+0.8 years) and 99 controls. Patients affected by dementia had higher CRP levels than controls (2.6+/-+/-0.2 vs. 0.7 + 0.1 p < 0.001, respectively). AD patients had higher CRP levels than VaD patients (4.2 + 0.6 vs. 1.7+/-0.2, p < 0.001, respectively). Stepwise multiple logistic regression analysis showed that dementia (odds ratio=OR=4.965, 95% confidence interval=Cl=1.402-13.23, p=0.004), fibrinogen (OR=1.011, Cl=1.007-1.015, p<0.001), and age (OR=1.158, Cl=1.063-1.261, p<0.001) are independently correlated with high levels of CRP. The study suggests that inflammation may have a pathogenetic role in AD.


Asunto(s)
Proteína C-Reactiva/metabolismo , Demencia/sangre , Inflamación/sangre , Anciano de 80 o más Años , Enfermedad de Alzheimer/sangre , Enfermedad de Alzheimer/complicaciones , Biomarcadores/sangre , Intervalos de Confianza , Demencia/complicaciones , Femenino , Estudios de Seguimiento , Humanos , Inflamación/complicaciones , Masculino , Oportunidad Relativa , Pronóstico , Estudios Retrospectivos , Índice de Severidad de la Enfermedad
20.
Alcohol Alcohol ; 19(3): 243-55, 1984.
Artículo en Inglés | MEDLINE | ID: mdl-6508879

RESUMEN

Alcoholism treatment units (ATUs) appear as the major institutional treatment system for alcoholics within the National Health Service. This paper is the first of a series of papers to report the results of a national survey on ATUs. It examines the varied treatment activities which are carried out in the institutional setting. Although the policies of many ATUs are based on a combination of group theory and eclecticism, there is a diversity of proceedings and treatment objectives. Future treatment provisions and their evaluation should consider the full range of influences that derive from patient characteristics and from institutional settings.


Asunto(s)
Alcoholismo/terapia , Unidades Hospitalarias/tendencias , Centros de Día , Registros de Hospitales , Humanos , Admisión del Paciente , Cooperación del Paciente , Alta del Paciente , Psicoterapia de Grupo , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA